Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Y9PH
|
|||
Former ID |
DNC010074
|
|||
Drug Name |
Phenylacetyl-Arg-Val-Arg-4-amidinobenzylamide
|
|||
Synonyms |
CHEMBL566340; phenylacetyl-Arg-Val-Arg-4-amidinobenzylamide; SCHEMBL7920067; GTPL6564; BDBM50303774
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C33H50N12O4
|
|||
Canonical SMILES |
CC(C)C(C(=O)NC(CCCN=C(N)N)C(=O)NCC1=CC=C(C=C1)C(=N)N)NC(=O)C(CCCN=C(N)N)NC(=O)CC2=CC=CC=C2
|
|||
InChI |
1S/C33H50N12O4/c1-20(2)27(45-30(48)25(11-7-17-41-33(38)39)43-26(46)18-21-8-4-3-5-9-21)31(49)44-24(10-6-16-40-32(36)37)29(47)42-19-22-12-14-23(15-13-22)28(34)35/h3-5,8-9,12-15,20,24-25,27H,6-7,10-11,16-19H2,1-2H3,(H3,34,35)(H,42,47)(H,43,46)(H,44,49)(H,45,48)(H4,36,37,40)(H4,38,39,41)/t24-,25-,27-/m0/s1
|
|||
InChIKey |
YGMAIAXBJLVVLI-KLJDGLGGSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Neuroendocrine convertase 1 (PCSK1) | Target Info | Inhibitor | [2] |
Neuroendocrine convertase 2 (PCSK2) | Target Info | Inhibitor | [2] | |
Reactome | Insulin processing | |||
WikiPathways | Insulin Processing | |||
Incretin Synthesis, Secretion, and Inactivation | ||||
Metabolism of amino acids and derivatives | ||||
Peptide hormone biosynthesis | ||||
Synthesis, Secretion, and Deacylation of Ghrelin |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6564). | |||
REF 2 | Potent inhibitors of furin and furin-like proprotein convertases containing decarboxylated P1 arginine mimetics. J Med Chem. 2010 Feb 11;53(3):1067-75. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.